Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

H1N1 a Seasonal Virus: The Moph Issues a List of Precautionary Steps

 
The Preventive Medical Service at the Ministry of Public Health noted that the influenza virus H1N1 has become part of the seasonal influenza since 2010.

In this context, the ministry mentioned the following:
 
  • The seasonal influenza is caused by viruses expected to appear and is characterized by the following symptoms: fever, severe respiratory symptoms such as coughing, throat and muscle pain, and sometimes vomiting and diarrhea. In case of complications, the patient is advised to seek medical help.
  • The virus is transmitted indirectly through coughs, sneezes and saliva. It can also be spread by contaminated hands when touching the mouth and nose.
  • If the patient is tested positive, the result does not mean that Oseltamivir (Flumivir- Tamiflu) should be taken for influenza, unless prescribed by the physician. 
Prevention from the influenza and the acute respiratory infections
 
  • Wash your hands frequently with water and soap, in particular after coughing, sneezing and touching contaminated surfaces and tools
  • Practice cough and sneeze etiquette
  • Avoid contact with infected persons
  • Stay home when showing the symptoms of influenza
  • Avoid habits that help transmit the infection, such as shaking hands and kissing
  • Follow a healthy and balanced diet, drink lots of warm fluids and eat fruits that are rich in vitamin C
  • Keep nurseries and school clean
  • People at risk such as children, the elderly, patients with chronic diseases, pregnant women and health care providers are advised to take the seasonal influenza vaccine.
ATC Name B/G Ingredients Dosage Form Price
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution+diluent 830,623 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution+diluent 7,236,698 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution 830,623 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 997,259 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 10,860,623 L.L
G03AA12 YASMIN B Drospirenone - 3mg, Ethinylestradiol - 30mcg Tablet, film coated 616,824 L.L
N06DA02 YASNAL Q-TAB G Donepezil - 10mg 10mg Tablet, orodispersible 1,376,095 L.L
N06DA02 YASNAL Q-TAB G Donepezil - 5mg 5mg Tablet, orodispersible 1,376,095 L.L
G03AA12 YAZ B Drospirenone - 3mg, Ethinylestradiol - 20mcg Tablet, film coated 1,193,332 L.L
J07BL01 YELLOW FEVER VACCINE, LIVE, FREEZE DRIED BioTech Yellow Fever virus, 17D strain - no less than 1600PFU/0.5ml Injectable lyophilisate for solution 3,527,587 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution 332,262,937 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution L.L
L01CX01 YONDELIS B Trabectedin - 1mg 1mg Injectable powder for solution 126,536,515 L.L
R03BB08 YUPELRI B Revefenacin - 175mcg/3ml 175mcg/3ml Inhalation solution 3,104,276 L.L
Sitemap
© Copyrights reserved to Ministry of Public Health 2026